{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:18:39Z","timestamp":1770513519892,"version":"3.49.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oxf Med Case Rep"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1093\/omcr\/omw061","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T22:48:25Z","timestamp":1469659705000},"page":"144-146","source":"Crossref","is-referenced-by-count":30,"title":["The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin"],"prefix":"10.1093","volume":"2016","author":[{"given":"Nellowe","family":"Candelario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jedrzej","family":"Wykretowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,7,27]]},"reference":[{"key":"2016072719481698000_2016.7.144.1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802710422"},{"key":"2016072719481698000_2016.7.144.2","doi-asserted-by":"crossref","unstructured":"Zaccardi F , Webb DR , Htike ZZ , Youssef D , Khunti K , Davies MJ. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Systematic review and network meta-analysis. Diabetes Obes Metab 2016; doi:10.1111\/dom.12670 . [Epub ahead of print] PubMed PMID: 27059700.","DOI":"10.1111\/dom.12670"},{"key":"2016072719481698000_2016.7.144.3","unstructured":"U.S. Food and Drug Administration Drug safety communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections [Internet]. 15 May 2015. Avaialbe from http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm475463.html (9 May 2016, date last accessed)."},{"key":"2016072719481698000_2016.7.144.4","unstructured":"Modi A , Agrawal A , Morgan F. Euglycemic diabetic ketoacidosis. Curr Diabetes Rev 2016; [Epub ahead of print] PubMed PMID: 27097605."},{"key":"2016072719481698000_2016.7.144.5","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12401"},{"key":"2016072719481698000_2016.7.144.6","first-page":"121","article-title":"Roles for insulin and glucagon in the development of ruminant ketosis\u2014a review","volume":"20","author":"Brockman","year":"1979","journal-title":"Can Vet J"},{"key":"2016072719481698000_2016.7.144.7","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1380"},{"key":"2016072719481698000_2016.7.144.8","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0843"},{"key":"2016072719481698000_2016.7.144.9","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.79.934.454"},{"key":"2016072719481698000_2016.7.144.10","first-page":"1656182","article-title":"Severe ketoacidosis associated with canagliflozin (Invokana): a safety concern","volume":"2016","author":"Gelaye","year":"2016","journal-title":"Case Rep Crit Care"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/omcr\/article-pdf\/2016\/7\/144\/6984714\/omw061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T09:43:57Z","timestamp":1503567837000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article-lookup\/doi\/10.1093\/omcr\/omw061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,27]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1093\/omcr\/omw061"],"URL":"https:\/\/doi.org\/10.1093\/omcr\/omw061","relation":{},"ISSN":["2053-8855"],"issn-type":[{"value":"2053-8855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}